| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 35,8 k € | +61.2% | 22,2 k € | -39.4% | 36,7 k € | +66.3% | 22,0 k € | -51.9% | 45,8 k € | -57.6% | 108,0 k € | +11.7% | 96,7 k € | -0.9% | 97,6 k € | +10.0% | 88,7 k € | +7.4% | 82,6 k € | +147.6% | 33,4 k € | +36.7% | 24,4 k € | -47.9% | 46,8 k € | +23.7% | 37,8 k € | -56.0% | 86,0 k € | +7.5% | 80,0 k € | +14.4% | 70,0 k € | +111.7% | 33,0 k € | +22.1% | 27,1 k € | |
| EBITDA | 4,1 k € | +155.5% | -7,3 k € | -268.9% | 4,3 k € | +149.6% | -8,7 k € | -166.0% | 13,3 k € | -82.2% | 74,3 k € | +19.9% | 62,0 k € | -17.0% | 74,6 k € | +23.2% | 60,6 k € | +10.8% | 54,7 k € | +1026.3% | 4,9 k € | +281.8% | -2,7 k € | -112.6% | 21,2 k € | +139.4% | 8,8 k € | -85.0% | 58,8 k € | +22.3% | 48,1 k € | -1.3% | 48,7 k € | +357.9% | 10,6 k € | +244.3% | 3,1 k € | |
| Operating profit | 3,4 k € | +144.2% | -7,8 k € | -298.7% | 3,9 k € | +141.6% | -9,4 k € | -94.5% | -4,8 k € | -109.6% | 50,6 k € | +293.6% | 12,9 k € | -73.6% | 48,7 k € | +31.8% | 37,0 k € | -4.2% | 38,6 k € | +602.3% | -7,7 k € | +50.1% | -15,4 k € | -289.0% | 8,1 k € | +278.2% | -4,6 k € | -109.3% | 49,0 k € | +28.8% | 38,1 k € | -3.5% | 39,4 k € | +2917.9% | 1,3 k € | +110.7% | -12,2 k € | |
| Profit/loss | 1,7 k € | +120.4% | -8,2 k € | -389.6% | 2,8 k € | +128.4% | -10,0 k € | -68.2% | -5,9 k € | -121.2% | 27,9 k € | +406.9% | 5,5 k € | -79.3% | 26,6 k € | +0.8% | 26,4 k € | -2.2% | 26,9 k € | +555.0% | -5,9 k € | +76.8% | -25,5 k € | -480.8% | 6,7 k € | +330.2% | -2,9 k € | -118.4% | 15,9 k € | -40.1% | 26,5 k € | -29.1% | 37,3 k € | +26541.3% | 140,1 € | +101.4% | -9,9 k € | |
| Equity | 283,3 k € | +0.6% | 281,6 k € | -2.8% | 289,8 k € | +1.0% | 287,0 k € | -3.4% | 296,9 k € | -2.0% | 302,9 k € | +10.2% | 274,9 k € | +2.0% | 269,4 k € | +10.9% | 242,9 k € | +12.2% | 216,5 k € | +14.2% | 189,6 k € | -3.0% | 195,5 k € | -11.6% | 221,0 k € | +3.1% | 214,3 k € | -1.3% | 217,2 k € | +7.9% | 201,4 k € | +15.1% | 174,9 k € | +27.1% | 137,5 k € | +0.1% | 137,4 k € | |
| Total assets | 293,8 k € | +2.6% | 286,5 k € | -4.7% | 300,6 k € | +2.3% | 293,8 k € | -14.7% | 344,3 k € | -6.6% | 368,8 k € | +4.2% | 353,9 k € | -0.5% | 355,7 k € | -4.9% | 374,2 k € | +55.7% | 240,3 k € | +20.2% | 199,9 k € | -3.2% | 206,5 k € | -10.9% | 231,8 k € | -3.8% | 240,8 k € | -0.1% | 241,2 k € | +10.1% | 219,1 k € | +19.2% | 183,8 k € | +29.8% | 141,6 k € | -0.5% | 142,4 k € | |
| Cash | 31,9 k € | +23.4% | 25,8 k € | -35.1% | 39,8 k € | +11.6% | 35,7 k € | -58.6% | 86,1 k € | -6.2% | 91,8 k € | +71.4% | 53,6 k € | -76.2% | 225,2 k € | -7.3% | 242,9 k € | +9.5% | 221,9 k € | +30.7% | 169,7 k € | -5.1% | 178,8 k € | +3.5% | 172,7 k € | +2.3% | 168,8 k € | -18.7% | 207,7 k € | +19.4% | 173,9 k € | +62.7% | 106,9 k € | +101.9% | 52,9 k € | -30.9% | 76,6 k € | |
| Debts | 9,8 k € | +101.6% | 4,9 k € | -55.1% | 10,8 k € | +58.6% | 6,8 k € | -85.6% | 47,4 k € | -23.5% | 62,0 k € | -18.5% | 76,0 k € | -11.8% | 86,2 k € | -32.7% | 128,1 k € | +438.9% | 23,8 k € | +153.6% | 9,4 k € | -13.4% | 10,8 k € | +4.4% | 10,4 k € | -59.9% | 25,9 k € | +10.4% | 23,5 k € | +33.5% | 17,6 k € | +100.2% | 8,8 k € | +122.7% | 3,9 k € | -18.8% | 4,9 k € | |
| Staff | — | — | — | — | — | 0,7 | 0,7 | 0,7 | 0,7 | 0,7 | 0,7 | 0,7 | 0,7 | 0,7 | 0,8 | 0,7 | 0,7 | 0,8 | 0,7 | |||||||||||||||||||
Public limited company · Bocholt · incorporated on 15/06/1994
Public limited company profitable and well capitalised. Cash position rising (+23.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Centrum voor Neurologie en Leerstoornissen is a Public limited company incorporated in 1994. Its main activity is: Specialist medical practice activities. Its registered office is in Bocholt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette